Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

A linkage between SmeIJK efflux pump, cell envelope integrity, and σE-mediated envelope stress response in Stenotrophomonas maltophilia.

Huang YW, Liou RS, Lin YT, Huang HH, Yang TC.

PLoS One. 2014 Nov 12;9(11):e111784. doi: 10.1371/journal.pone.0111784. eCollection 2014.

2.

MacABCsm, an ABC-type tripartite efflux pump of Stenotrophomonas maltophilia involved in drug resistance, oxidative and envelope stress tolerances and biofilm formation.

Lin YT, Huang YW, Liou RS, Chang YC, Yang TC.

J Antimicrob Chemother. 2014 Dec;69(12):3221-6. doi: 10.1093/jac/dku317. Epub 2014 Aug 19.

PMID:
25139838
3.

Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitis.

Racine-Poon A, Botta L, Chang TW, Davis FM, Gygax D, Liou RS, Rohane P, Staehelin T, van Steijn AM, Frank W.

Clin Pharmacol Ther. 1997 Dec;62(6):675-90.

PMID:
9433396
4.

Structural features of the extracellular portion of membrane-anchoring peptides on membrane-bound immunoglobulins.

Major JG Jr, Davis FM, Liou RS, Chang TW.

Mol Immunol. 1996 Feb;33(2):179-87.

PMID:
8649439
5.

A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120.

Günthard HF, Gowland PL, Schüpbach J, Fung MS, Böni J, Liou RS, Chang NT, Grob P, Graepel P, Braun DG, et al.

J Infect Dis. 1994 Dec;170(6):1384-93.

PMID:
7995976
6.

Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.

Major JG, Liou RS, Sun LK, Yu LM, Starnes SM, Fung MS, Chang TW, Chang NT.

Hum Antibodies Hybridomas. 1994;5(1-2):9-17.

PMID:
7858187
7.

Can anti-IgE be used to treat allergy?

Davis FM, Gossett LA, Pinkston KL, Liou RS, Sun LK, Kim YW, Chang NT, Chang TW, Wagner K, Bews J, et al.

Springer Semin Immunopathol. 1993;15(1):51-73. Review.

PMID:
8362344
8.

Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 disease.

Schüpbach J, Günthard H, Fung MS, Liou RS, Botta L, Gowland P, Gordon W, Gygax D, Chang NT, Chang TW, et al.

Biotherapy. 1993;6(3):205-15.

PMID:
8292461
9.

Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.

Fung MS, Sun CR, Gordon WL, Liou RS, Chang TW, Sun WN, Daar ES, Ho DD.

J Virol. 1992 Feb;66(2):848-56.

10.

A new isoform of human membrane-bound IgE.

Peng C, Davis FM, Sun LK, Liou RS, Kim YW, Chang TW.

J Immunol. 1992 Jan 1;148(1):129-36.

PMID:
1727861
11.

Mouse/human chimeric anti-HIV-1 gp120 antibody to the principal neutralizing determinant: tolerability and pharmacokinetics in cynomolgus monkeys, Macaca fascicularis.

Liou RS, Fung MS, Zühlke U, Gudat F, McKinney S, Gordon W, Bee W, Botta L, Gygax D, Chang TW, et al.

Biotherapy. 1992;5(4):291-9.

PMID:
1283953
12.

Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificity.

Sun LK, Liou RS, Sun NC, Gossett LA, Sun C, Davis FM, MacGlashan DW Jr, Chang TW.

J Immunol. 1991 Jan 1;146(1):199-205.

PMID:
1701791
13.

Two isoforms of human membrane-bound alpha Ig resulting from alternative mRNA splicing in the membrane segment.

Yu LM, Peng C, Starnes SM, Liou RS, Chang TW.

J Immunol. 1990 Dec 1;145(11):3932-6.

PMID:
2246519
14.

Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.

Fung MS, Sun CR, Liou RS, Gordon W, Chang NT, Chang TW, Sun NC.

J Immunol. 1990 Oct 1;145(7):2199-206.

PMID:
2398276
15.
16.

Preliminary crystallographic analysis of the Fab fragment of an antibody against HIV gp120.

Vyas MN, Vyas NK, Liou RS, Chang TW, Quiocho FA.

J Mol Biol. 1990 Jul 5;214(1):23-4.

PMID:
1695249
17.

A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells.

Liou RS, Rosen EM, Fung MS, Sun WN, Sun C, Gordon W, Chang NT, Chang TW.

J Immunol. 1989 Dec 15;143(12):3967-75.

PMID:
2480382
18.

Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120.

Sun NC, Ho DD, Sun CR, Liou RS, Gordon W, Fung MS, Li XL, Ting RC, Lee TH, Chang NT, et al.

J Virol. 1989 Sep;63(9):3579-85.

19.

Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV.

Ratner L, Fisher A, Jagodzinski LL, Liou RS, Mitsuya H, Gallo RC, Wong-Staal F.

Haematol Blood Transfus. 1987;31:404-6. No abstract available.

PMID:
3443402
20.

Complete nucleotide sequences of functional clones of the AIDS virus.

Ratner L, Fisher A, Jagodzinski LL, Mitsuya H, Liou RS, Gallo RC, Wong-Staal F.

AIDS Res Hum Retroviruses. 1987 Spring;3(1):57-69.

PMID:
3040055
21.

Factors affecting the activation of rabbit muscle phosphofructokinase by actin.

Kuo HJ, Malencik DA, Liou RS, Anderson SR.

Biochemistry. 1986 Mar 25;25(6):1278-86.

PMID:
2938627
22.

Molecular cloning and analysis of the endogenous retrovirus chemically induced from RFM/Un mouse cell cultures.

Liou RS, Boone LR, Kiggans JO, Yang DM, Wang TW, Tennant RW, Yang WK.

J Virol. 1983 Apr;46(1):288-92.

23.

Control of RFM strain endogenous retrovirus in RFM mouse cells.

Tennant RW, Otten JA, Wang TW, Liou RS, Brown A, Yang WK.

J Virol. 1983 Jan;45(1):47-54.

24.

Activation of rabbit muscle phosphofructokinase by F-actin and reconstituted thin filaments.

Liou RS, Anderson S.

Biochemistry. 1980 Jun 10;19(12):2684-8.

PMID:
6446931
25.

Binding of ATP and of 1,N6-ethenoadensone triphosphate to rabbit muscle phosphofructokinase.

Liou RS, Anderson SR.

Biochemistry. 1978 Mar 21;17(6):999-1004.

PMID:
147103
26.

Proceedings: Permeability of mouse urinary bladder.

Elliott AB, Liou RS.

J Physiol. 1974 Sep;241(2):114P-115P. No abstract available.

Supplemental Content

Support Center